VEGFA derived from PMCs acts on VEGFR1 in GC cells in a hypoxic microenvironment, activating the p-ERK/p-JNK pathway, increasing integrin α5 and fibronectin expression, and promoting PM of GC. The gene discussed is FLT1; the disease is gastric cancer.